Innovating Works

ATMO BFC

Desconocido
EUCITYCALC: European City Calculator Prospective modelling tool supporting public authorities in reaching clima... In order for Europe’s transition towards climate neutrality to succeed, cities need to be in the driving seat. European cities are at the fo...
2021-05-06 - 2024-08-31 | Financiado
RESPONSE: integRatEd Solutions for POsitive eNergy and reSilient CitiEs ATMO BOURGOGNE FRANCHE COMTE participó en un H2020: H2020-LC-SC3-2018-2019-2020 "RESPONSE supports the Lighthouse cities of Dijon (FR) and Turku (FI) and their Fellow cities Brussels (BE), Zaragoza (ES), Botosani (RO), P...
2020-08-31 - 2025-09-30 | Financiado
QUALITOP: Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy an Open smart d... ATMO BOURGOGNE FRANCHE COMTE participó en un H2020: H2020-SC1-DTH-2018-2020 "Cancer immunotherapy brought about significant progress in cancer treatment. It resulted in high efficacy in some cancers; e.g., up to 60%...
2019-10-28 - 2024-06-30 | Financiado
R-LiNK: Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I di... ATMO BOURGOGNE FRANCHE COMTE participó en un H2020: H2020-SC1-2016-2017 Bipolar disorder (BD) is a prevalent mental disorder and a leading cause of suicide. Lithium (Li) is the key mood stabilizer for prevention...
2017-11-21 - 2024-06-30 | Financiado
RESSTORE: REgenerative Stem cell therapy for STroke in Europe ATMO BOURGOGNE FRANCHE COMTE participó en un H2020: H2020-PHC-2014-2015 Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and co...
2015-09-15 - 2020-08-31 | Financiado
SECURE: Secondary prEvention of CardiovascUlaR disease in the Elderly trial ATMO BOURGOGNE FRANCHE COMTE participó en un H2020: H2020-PHC-2014-2015 While Cardiovascular diseases (CVD) are the main cause of death worldwide, they are responsible for half of all deaths in Europe. The overal...
2015-04-08 - 2021-12-31 | Financiado
COMBACTE-NET: Combatting Bacterial Resistance in Europe ATMO BOURGOGNE FRANCHE COMTE participó en un FP7: The emergence of Antibiotic-resistant bacteria (ARB) is a global problem, having recently been elevated to the top three threats identified...
Financiado
VIAMOS: Vertically integrated Array type Mirau based OCT System for early diagnostics of skin cancer Skin cancer is the most commonly diagnosed type of cancer. Its early diagnosis is essential since it can be treated more effectively when de...
Financiado
INTREALL: International study for treatment of childhood relapsed ALL 2010 with standard therapy systematic i... ATMO BOURGOGNE FRANCHE COMTE participó en un FP7: Though survival of children with acute lymphoblastic leukaemia (ALL) has improved, relapse remains a leading cause of mortality in childhood...
Financiado
uRALP: Micro Technologies and Systems for Robot Assisted Laser Phonomicrosurgery ATMO BOURGOGNE FRANCHE COMTE participó en un FP7: Lasers form an increasingly common tool for precision treatment of pathological conditions on delicate and vital human organs. Laser phonomi...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.